Focus on the coastal market, property and casualty insurance company Safepoint Holdings (SFPT.US) applied for a US stock IPO, planning to raise $250 million.
Focused on property and casualty insurance in coastal areas, Safepoint Holdings (SFPT.US), a platform-based company, submitted an application for listing to the U.S. Securities and Exchange Commission (SEC) last Friday.
Focus on coastal property and casualty insurance underwriters and platform-based enterprises Safepoint Holdings (SFPT.US) submitted a listing application to the U.S. Securities and Exchange Commission (SEC) last Friday, expecting to raise up to $250 million through an initial public offering (IPO).
Safepoint Holdings is a specialized property insurance company focused on the coastal market, with its main operations in Florida and Louisiana, serving residential homeowners and small commercial policyholders. The company operates on a fee-based model, managing the insurance full value chain, owning a wholly-owned insurance subsidiary, and managing a reciprocal insurance exchange owned by policyholders, where Safepoint serves as the attorney-in-fact. The company currently has over $1 billion in gross premiums written, the majority of which comes from the reciprocal exchange. Through this structured design, Safepoint maximizes capital efficiency - its revenue mainly comes from service fees generated by managing the premium volume, rather than assuming balance sheet risks.
Headquartered in Tampa, Florida, the company was founded in 2013. In the 12 months ending on March 31, 2026, the company reported revenues of $572 million. Safepoint Holdings plans to list on the New York Stock Exchange (NYSE) under the ticker symbol "SFPT." The company confidentially submitted its listing application on November 26, 2025. Deutsche Bank, Morgan Stanley, Keefe Bruyette Woods, Citizens JMP, Piper Sandler, Truist Securities, and William Blair are the joint book-running managers for this offering.
Related Articles

INT MEDICAL (01501) received notification from the China Securities Regulatory Commission regarding the application for the full circulation of H shares.

Viva Biotech (01873) spent 1.8551 million Hong Kong dollars to repurchase 1.1935 million shares on May 11th.

PW MEDTECH (01358) purchased 2.4149 million Hong Kong dollars to repurchase 2.044 million shares on May 11th.
INT MEDICAL (01501) received notification from the China Securities Regulatory Commission regarding the application for the full circulation of H shares.

Viva Biotech (01873) spent 1.8551 million Hong Kong dollars to repurchase 1.1935 million shares on May 11th.

PW MEDTECH (01358) purchased 2.4149 million Hong Kong dollars to repurchase 2.044 million shares on May 11th.

RECOMMEND

Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026

HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026

The Chip Stock Frenzy Is Still Accelerating
11/05/2026


